Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Turn Therapeutics Inc. (TTRX) Institutional Ownership & Insider Trading

29 institutions reported holding Turn Therapeutics Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 9 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

TTRXTurn Therapeutics Inc.Follow TTRX — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
306.2M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

29 institutions held 3.9% of the shares. Across filers that reported both quarters, shares held changed +146.9%.

Increased+4New+10Decreased-2Closed-2

Largest moves, shares (millions)

SteelPeak Wealth+0.2MIeq Capital+0.2MBlackRock+0.0MXTX Topco-0.0MHodges Capital Management-0.0MMillennium Management-0.0M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Dec 25-0.0Mar 26+0.7Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26291+146.9%41022
Mar 26200-8.2%3124
Dec 25220—————

Turn Therapeutics Inc. — questions

Who owns Turn Therapeutics Inc. stock?
29 institutions reported Turn Therapeutics Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: SteelPeak Wealth, LLC (0.8%), IEQ CAPITAL, LLC (0.8%), DDFG, Inc (0.4%).
Are Turn Therapeutics Inc. insiders buying or selling?
9 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Turn Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.